Skip to main content
. 2017 May;91(5):545–553. doi: 10.1124/mol.116.107524

Fig. 3.

Fig. 3.

Top: By using the Cre-loxP recombination technology, the hepatocyte- or intestinal enterocyte-specific deletion of the Ugt1a1 gene (Ugt1ΔHep or Ugt1ΔIE) was achieved. The bottom diagram shows the impact of the tissue-specific deletion of the Ugt1a1 gene on serum bilirubin levels.